Menopause and cardiovascular disease

References

• Kannel W B, Hjortland M C, McNamara P M, Gordon T. Menopause and the risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976; 85: 447–52
   PubMed Web of Science ®Google Scholar
• Gordon T, Kannel W B, Ljortland H MC, McNamara P M. Menopause and coronary heart disease: the Framingham study. Ann Intern Med 1978; 89: 151–61
   Web of Science ®Google Scholar
• Colditz G A, Willett W C, Stampfer M J, Rosner B, Speizer F E, Hennekens C H. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 316: 1105–10
   PubMed Web of Science ®Google Scholar
• Parrish H M, Carr C A, Hall D G, King T M. Time intervals from castration in premenopausal women to development of excessive coronary atherosclerosis. Am J Obstet Gynecol 1967; 99: 155–62
   PubMed Web of Science ®Google Scholar
• Robinson R W, Higano N, Cohen W D. Increased incidence of coronary heart disease in women castrated prior to the menopause. Arch Intern Med 1959; 104: 908–13
   PubMedGoogle Scholar
• McGill H C, Jr. Sex steroid hormone receptors in the cardiovascular system. Postgrad Med 1989; 64–8
   PubMedGoogle Scholar
• Ylikorkala O, Kuusi T, Tikkanen M J, Vlinikka L. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins. J Clin Endocrinol Metab 1987; 65: 1238–42
   PubMed Web of Science ®Google Scholar
• Nederlandse Hartstichting. Hart- en vaatziekten in Nederland. Den Haag 1995
   Google Scholar
• Tracy R E. Sex difference in coronary disease: two opposing views. J Chron Dis 1966; 19: 1245–51
   PubMedGoogle Scholar
• Kawachi I, Colditz G A, Stampfer M J, Willett W C, Manson J AE, Rosner B, Hunter D J, Hennekens C H, Speizer F E. Smoking cessation in relation to total mortality rates in women; a prospective cohort study. Ann Intern Med 1993; 119: 992–1000
   PubMed Web of Science ®Google Scholar
• Verschuren W MM, Achterberg P W, Bijnen F CH, Bueno de Mesquita H B, Feskens E JM, van Leer E M, Peeters P HM, Seidell J C, Smit H A, Verkleij H. Populatie attributieve risico's. Volksgezondheid toekomst verkenning RIVM SdUUitgeverij Plantijnstraat, D Ruwaard, P GN Kramers, Den Haag 1993
   Google Scholar
• Dawber T R. The Framingham study. The epidemiology of atherosclerotic disease. Harvard University Press, MassachusettsUSA 1980
   Google Scholar
• Weiss N S. Relationship of menopause to serum cholesterol and arterial blood pressure. The United States health examination survey of adults. Am J Epidemiol 1972; 96: 237–41
   PubMed Web of Science ®Google Scholar
• Lindquist O, Bengtsson C. Serum lipids, arterial blood pressure and body weight in relation to the menopause: results from a population study of women in Göteborg. Sweden. Scand J Clin Lab Invest 1980; 40: 629–36
   PubMed Web of Science ®Google Scholar
• Bonithon-Kopp C, Scarabin P Y, Darne B, Malmejac A, Guize L. Menopause-related changes in lipoproteins and some other cardiovascular risk factors. Int J Epidemiol 1990; 19: 42–8
   PubMed Web of Science ®Google Scholar
• van Berestijn E CH, Riedstra M, van der Wei A, Schouten E G, Burema J, Kok F J. Habitual dietary calcium intake and blood pressure change around the menopause: a longitudinal study. Int J Epidemiol 1992; 21: 683–9
   PubMed Web of Science ®Google Scholar
• Hjortland M C, McNamara P M, Kannel W B. some atherogenic concomitants of menopause: the Framingham study. Am J Epidemiol 1976; 103: 304–11
   PubMed Web of Science ®Google Scholar
• Matthews K A, Meilahn E, Kuller L H, Kelsey S F, Caggiula A W, Wing R R. Menopause and risk factors for coronary heart disease. N Engl J Med 1989; 321: 641–6
   PubMed Web of Science ®Google Scholar
• Meade T W, Dyer S, Howarth D J, Imeson J D, Stirling Y. Antithrombin III and procoagulant activity, sex differences and effects of the menopause. Br J Haematol 1990; 74: 77–81
   PubMed Web of Science ®Google Scholar
• Kannel W B, Hjortland M C, McNamara P M, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976; 85: 447–52
   PubMed Web of Science ®Google Scholar
• Bush T L, Cowan L, Heiss G, Chambliss L, Wallace R. Ovarian function and lipid/lipoprotein levels. Results from the lipid research clinics program (abstract). Am J Epidemiol 1984; 120: 489
   Google Scholar
• Campos H, McNamara J R, Wilson P WF, Ordovas J M, Schaefer E J. Differences in low density lipoprotein subfractions and apolipoprotein in premenopausal and postmenopausal women. J Clin Endocrinol Metab 1988; 67: 30–5
   PubMed Web of Science ®Google Scholar
• Witteman J CM, Grobbee D E, Kok F J, Hofman A, Valkenburg H A. Increased risk of atherosclerosis in women after the menopause. Br Med J 1989; 298: 642–4
   PubMed Web of Science ®Google Scholar
• Pansini F, Bonaccorsi G, Calisesi M, Campobasso C, Franze G P, Gilli G, Locorotondo G, Mallica G. Influence of spontaneous and surgical menopause on atherogenic metabolic risk of atherosclerosis in women after the menopause. Maturitas 1993; 17: 181–90
   PubMed Web of Science ®Google Scholar
• Wu Z Y, Wu X K, Zhang Y W. Relationship of menopausal status and sex hormones to serum lipids and blood pressure. Int J Epidemiol 1990; 19: 297–302
   PubMed Web of Science ®Google Scholar
• Jensen J, Nilas L, Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas 1990; 12: 321–31
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E L. Obesity, atherosclerosis, and coronary artery disease. Ann Intern Med 1985; 103: 1010–19
   PubMed Web of Science ®Google Scholar
• Ostlund R E, Jr, Staten M, Kohrt W M, Schulz J, Malley M. The ratio of waist-to-hip circumference, plasma insulin level, and glucose intolerance as independent predictors of the HDL cholesterol level in older adults. N Engl J Med 1990; 322: 229–34
   PubMed Web of Science ®Google Scholar
• Edwards D AW. Differences in the distribution of subcutaneous fat with sex and maturity. Clin Sci 1951; 10: 305–15
   PubMed Web of Science ®Google Scholar
• Ley C J, Lees B, Stevenson J C. Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr 1992; 55: 950–4
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E L, Bush T L. Oestrogen and coronary heart disease in women. J Am Med Assoc 1991; 265: 1861–7
   PubMed Web of Science ®Google Scholar
• Colditz G A, Willett W C, Stampfer M J, Posner B, Speizer F E, Hennekens C H. A prospective study of age at menarche, parity, age at first birth and coronary heart disease in women. Am J Epidemiol 1987; 126: 861–70
   PubMed Web of Science ®Google Scholar
• Robinson R W, Higano N, Cohen W D. Increased incidence of coronary heart disease in women castrated prior to menopause. Arch Intern Med 1959; 104: 908–13
   PubMedGoogle Scholar
• van der Schouw Y T, van der Graaf Y, Steyerberg E W, Eijkemans M JC, Banga J D. Age at menopause as a risk factor for cardiovascular mortality. Lancet 1996; 347: 714–8
   PubMed Web of Science ®Google Scholar
• Stampfer M J, Colditz G A. Oestrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47–63
   PubMed Web of Science ®Google Scholar
• Ross R K, Paganini-Hill A, Mack T M, Arthur M, Henderson B E. Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet 1981; 1: 858–60
   PubMed Web of Science ®Google Scholar
• Wilson P W, Garrison R J, Castelli W P. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50: The Framingham Study. N Engl J Med 1985; 313: 1038–43
   PubMed Web of Science ®Google Scholar
• Grodstein F, Stampfer M J, Manson J, Colditz G A, Willett W C, Rosner B, Speizer F E, Hennekens C H. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453–61
   PubMed Web of Science ®Google Scholar
• Miller V T, Muesing R A, LaRosa J C, Story D B, Philips E A, Stillman R J. Effects of conjugated equine estrogen with and without mrce different progestogens on lipoproteins, high-density lipoprotein subtractions, and apolipoprotein A-l. Obstet Gynecol 1991; 77: 235–40
   PubMed Web of Science ®Google Scholar
• Burch J C, Byrd B F, Jr, Vaughn W K. The effects of long-term estrogen on hysterectomized women. Am J Obstet Gynecol 1974; 188: 778–82
   Google Scholar
• MacMahon B. Cardiovascular disease and non-contraceptive oestrogen therapy. Coronary Heart Disease in Young Women, M F Oliver. Churchill Livingstone, New York 1978; 197–207
   Google Scholar
• Hunt K, Vessey M, McPherson K, Coleman M. Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynecol 1987; 94: 620–35
   PubMedGoogle Scholar
• Vandenbroucke J P. How much of the cardioprotective effect of postmenopausal oestrogens is real?. (Editorial) Epidemiology 1995; 6: 207–8
   PubMed Web of Science ®Google Scholar
• Posthuma W FM, Westendorp R GJ, Vandenbroucke J P. Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?. Br Med J 1994; 308: 1268–9
   PubMed Web of Science ®Google Scholar
• Hemminkj E, Sihvo S. A review of postmenopausal hormone therapy recommendations potential for selection bias. Obstet Gynecol 1993; 82: 1021–8
   PubMed Web of Science ®Google Scholar
• Sturgeon S R, Schairer C, Brinton L A, Pearson T, Hoover R N. Evidence of a healthy oestrogen user survivor effect. Epidemiology 1995; 6: 227–31
   PubMed Web of Science ®Google Scholar
• Grady D, Rubin S M, Petitti D B, Fox C F, Black D, Ettinger B, Ernster V L, Cummings S R. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Int Med 1992; 117: 1016–37
   PubMed Web of Science ®Google Scholar
• The Writing group of the PEPI trial. Rationale, design, and conduct of the PEPI trial. Controlled Clinical trials 1995; 16: 3S–19S
   PubMedGoogle Scholar
• The Writing group of the PEPI trial. Effects of oestrogen or oestrogen/progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal oestrogen/progestin interventions (PEPI) trial. J Am Med Assoc 1995; 273: 199–208
   Web of Science ®Google Scholar